Central Nervous System Stimulants
"Central Nervous System Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
| Descriptor ID |
D000697
|
| MeSH Number(s) |
D27.505.696.282 D27.505.954.427.220
|
| Concept/Terms |
Analeptics- Analeptics
- Analeptic Drugs
- Drugs, Analeptic
- Analeptic Agents
- Agents, Analeptic
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Stimulants".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Stimulants".
This graph shows the total number of publications written about "Central Nervous System Stimulants" by people in this website by year, and whether "Central Nervous System Stimulants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 0 | 2 |
| 2017 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Central Nervous System Stimulants" by people in Profiles.
-
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics. J Addict Med. 2023 May-Jun 01; 17(3):e141-e147.
-
Treatment of attention deficit/hyperactivity disorder in children with CHD. Cardiol Young. 2021 Jun; 31(6):969-972.
-
Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder. J Autism Dev Disord. 2017 Jan; 47(1):144-154.
-
Mixed-amphetamine salts increase abstinence from marijuana in patients with co-occurring attention-deficit/hyperactivity disorder and cocaine dependence. Am J Addict. 2016 12; 25(8):666-672.
-
Measures of outcome for stimulant trials: ACTTION recommendations and research agenda. Drug Alcohol Depend. 2016 Jan 01; 158:1-7.
-
The Association Between Stimulant, Opioid, and Multiple Drug Use on Behavioral Health Care Utilization in a Safety-Net Health System. Subst Abus. 2015; 36(4):407-12.
-
Maternal caffeine intake during pregnancy and risk of obesity in offspring: a prospective cohort study. Int J Obes (Lond). 2015 Apr; 39(4):658-64.
-
Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr. 2014 Sep; 35(7):448-57.
-
Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Curr Med Res Opin. 2014 Aug; 30(8):1687-99.
-
National trends in psychostimulant-related deaths: 1999-2009. Subst Abus. 2013; 34(2):129-36.